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During an epidemiologic survey of rotavirus infections established to monitor the prevalent G serotypes circulating in the
United States, human P[6]G9, subgroup I rotavirus strains causing symptomatic infections were identified as the fourth most
common serotype. In this report we describe the molecular and antigenic characterization of one of these P[6]G9 isolates
(US1205). Neutralization and sequencing studies have demonstrated that both outer capsid proteins, VP7 and VP4, of US1205
are closely related to but genetically and antigenically distinguishable from those of standard G9 strains (e.g., F45, WI61) and
standard P2A[6] strains (e.g., ST3, M37). Thus the complete antigenic type of US1205 is P2A[6]G9, subgroup I. Sequence
analysis of the VP6 and NSP4 genes of US1205 indicates that strain US1205 possessed VP6 subgroup I and NSP4A genotype
specificities. Finally, Northern hybridization studies suggest that the P[6]G9 strains are closely related to members of the
DS-1 genogroup except for their P[6] VP4 gene, which has been commonly identified in strains of both major human
genogroups, and their G9 VP7 gene, which may have been derived by reassortment with a Wa genogroup strain. Examination
of historic collections and prospective surveillance of strains will be needed to determine whether this strain has been
present for some time or if it is emerging to compete with the other common serotypes of rotavirus. © 1999 Academic Press
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9INTRODUCTION
Group A rotaviruses are the major cause of severe
astroenteritis in infants and young children worldwide,
ausing an estimated 600,000 to 870,000 deaths each
ear in developing countries. In the United States few
eaths occur (approximately 20 per year), but rotavirus-
ssociated economic loss is estimated at greater than 1
illion dollars per year (Tucker et al., 1998; Kapikian and
hanock, 1996). Vaccines are considered the best hope
or controlling rotavirus disease, and a vaccine is li-
ensed for use in the United States and possibly else-
here within a year (Bernstein et al., 1995; Rennels et al.,
996). The vaccine has been constructed to provide
overage against the four most common serotypes, G1 to
4, found worldwide. Since large variations of G sero-
ypes have been documented in several developing
ountries, it will be important to conduct strain surveil-
ance in countries using or considering use of the current
The U.S. Government’s right to retain a nonexclusive royalty-free
icense in and to the copyright covering this paper, for governmental
urposes, is acknowledged.
1 To whom correspondence and reprint requests should be ad-
ressed at Viral Gastroenteritis Section, MS G-04, Division of Viral and
ickettsial Diseases, Centers for Disease Control and Prevention, 1600
lifton Road N.E., Atlanta, GA 30333. Fax: (404) 639-3645. E-mail:oek4@cdc.gov.
45accine to monitor serotype trends before and after a
accination program begins.
Rotaviruses contain two outer capsid proteins, VP7
nd VP4, which independently elicit neutralizing antibod-
es and specify the virus G and P serotypes, respectively.
o date, 10 distinct G serotypes and 8 P serotypes have
een identified in humans (Estes, 1996; Timenetsky et al.,
997). A recent review of epidemiological surveys con-
ucted worldwide illustrates that the majority of strains
ausing infection requiring hospitalization of humans fall
nto four main groups: P[8]G1, P[8]G3, P[8]G4, and P[4]G2
Gentsch et al., 1996). These surveys have utilized geno-
yping methods to determine P type since routine sero-
ogic methods for P serotyping have not been easy to
evelop (Gentsch et al., 1992). Based on comparisons of
ntigenic and genetic methods of P type, genotypes P[4],
[6], and P[8] correspond to P serotypes 1B, 2A, and 1A,
espectively. By convention P types determined only by
enotyping are described by P followed by genotype
umber in brackets (e.g., P[6]); P serotype designation
e.g., P2A) is reserved for culture adapted strains whose
serotype has been determined by cross-neutralization
Estes, 1996).
Human isolates with nonstandard G serotype and P
enotype combinations and types, such as G types 6, 8,
, 10, and 12 and P types [6] and [9], have constituted
nly a minor portion of cases identified. However, some
0042-6822/99 $30.00
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46 KIRKWOOD ET AL.f these rare serotypes are present at high frequency in
ome regions. For example, serotype G9 strains that
ere first isolated in the United States (Clark et al., 1987)
nd that have been detected several times in Japan
Nakagomi et al., 1988, 1990) and once in Thailand (Ura-
awa et al., 1992) have in more recent investigations
een commonly associated with diarrhea in India (Ra-
achandran et al., 1996), Malawi (Cunliffe et al., 1999),
nd Bangladesh (Unicomb et al., manuscript submitted
or publication). Strains with a P[6] genotype that were
hought to be associated predominantly with asymptom-
tic or mildly symptomatic infection in newborns (Estes
nd Cohen, 1989) have also been recently reported as a
ommon cause of symptomatic infection in surveys of
nfants with diarrhea in developing countries such as
ndia, Bangladesh, and Brazil (Ramachandran et al.,
996; Timenetsky et al., 1994; Unicomb et al., manuscript
ubmitted for publication).
In anticipation of routine vaccination against rotavirus,
e recently established a strain surveillance program in
he United States and characterized approximately 350
trains collected from 10 U.S. cities during the 1996–1997
otavirus season (Ramachandran et al., 1998). In this
tudy, serotype P[8]G1 was the most common, with se-
otype P[4]G2 and P[8]G3 second and third most preva-
ent. However, the fourth most common overall in the
nited States detected in 4 different cities was a strain
hat had a short electropherotype with the unusual sero-
ype combination of P[6]G9 and subgroup I specificity
Ramachandran et al., 1998). This represented the first
eport of the common occurrence of serotype G9 in
ultiple regions of a developed country and together
ith other recent reports raises important questions
bout the global importance of this serotype. Since the
irst vaccines to be licensed have been developed with
eassortant strains intended to confer serotype-specific
mmunity against the four common serotypes, the emer-
ence of G9 strains has raised questions about whether
he vaccine will protect against this serotype as well or
hether an additional reassortant strain will need to be
dded to improve vaccine efficacy.
TABLE 1
Neutralization Resistance Pattern of US1205 by Hyperimmune Sera
to the G9 Strain 116E and the Reassortant UKxWI61
Hyperimmune
antisera
Virus strain (serotype)
US1205
(9)
F45
(9)
M37
(1)
DS-1
(2)
P
(3)
ST3
(4)
16E
(P8[11]G9)
3900 24,000 210 330 190 230
I61xUK
(P[5]G9)
19,000 62,000 520 380 ,100 ,100In this report we describe the molecular and antigenic Wharacteristics of a representative of the P[6]G9 strains
solated from children with diarrhea in the United States.
e have characterized this strain, designated US1205,
oth genetically (nucleic acid sequence determination
nd hybridization analysis) and antigenically (N-MAbs
nd hyperimmune antisera) and compared it with previ-
usly identified standard strains.
RESULTS
and P serotype analysis
ur preliminary characterization of strain US1205 by nu-
leotide sequencing and binding to a G9-specific N-MAb
uggested that this strain belonged to serotype G9 (Ra-
achandran et al., 1998). To provide additional evidence,
e performed neutralization studies with hyperimmune
ntisera raised to other serotype G9 strains.
The results of neutralization assays using US1205 and
tandard rotavirus strain F45 against hyperimmune anti-
era raised to 116E (P8[11]G9) and the reassortant
I61xUK showed that both US1205 and F45 were neu-
ralized to a similar degree (Table 1). Standard rotavirus
trains M37 (P2A[6]G1), DS-1 (P1B[4]G2), P(P1A[8]G3),
nd ST3 (P2A[6]G4) were not neutralized by either of the
yperimmune sera, suggesting that strain US1205 be-
ongs to serotype G9.
We then determined the P serotype of US1205 by
laque reduction neutralization assays using hyperim-
une antisera raised to four different reassortant strains
Table 2). Strain US1205 was neutralized to a significant
iter by the hyperimmune antiserum raised against
T3xDS21 but not by any of the other hyperimmune sera
xcept WaxDS-1 at low level, suggesting that it belongs
o serotype P2A.
Further antigenic analysis of strain US1205 was con-
ucted by neutralization experiments using four VP7-
pecific and three VP4-specific N-MAbs (Tables 3 and 4).
-MAb F45:1, which targets the antigenic C region of VP7
TABLE 2
Reciprocal of 60% Plaque Reduction Neutralization Titer of Guinea
Pig Hyperimmune Antiserum to Indicated Reassortant
Hyperimmune antisera
to reassortant
Virus strain
US1205
(P[6]G9)
WaxDS-1 160
(P1A, G2) (2560)a
DS-1xUK ,80
(P1B, G6) (2560)a
DS-1xKC-1 ,80
(P1B, G10) (5120)a
ST3xDS-1 2560
(P2A, G2) (5120)a
a Reciprocal of 60% PRN antibody titer to VP4-homologous virus (e.g.,
a virus vs Anti-WaxDS-1 antiserum, 1:2560).
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47CHARACTERIZATION OF A SEROTYPE P[6]G9 HUMAN ROTAVIRUS STRAINKirkwood et al., 1993), neutralized US1205 to a titer
ourfold lower than the P1A[8]G9 strain F45. US1205 was
eutralized to a very low titer by the antigenic A region
-MAb WI61:1 and was not neutralized by N-MAbs F45:8
nd F45:9 (data not shown). All A region N-MAbs neu-
ralized F45 to high titer.
The VP4-specific N-MAbs HS-6 and HS-16 showed
imilar neutralization patterns. Both neutralized the stan-
ard P2A strains M37 and ST3 but did not neutralize
S1205. The low neutralization titers obtained for N-MAb
S-6 are in agreement with the results of Padilla-Norigea
t al. (1993). The P1A-P2A cross-reactive N-MAb F45:4
eutralized US1205 and ST3 to a similar but low titer and
37 and F45 to a titer 5-fold and 50-fold higher, respec-
ively. Thus the VP4 protein of US1205 contains antigenic
ifferences when compared to the standard P2A strains
T-3 and M37. Since the N-MAbs HS-6 and HS-16 were
nable to neutralize US1205, these N-MAbs would prob-
bly not be useful in VP4 serotyping studies of U.S.
trains.
equence analysis
he nucleotide sequence of gene segment 4, encoding
P4, of US1205 and its deduced amino acid sequence
ere determined and compared with the corresponding
equences of representative strains of the human P
enotype [4], [6], [8], [9], and [10] (Table 5). As expected,
train US1205 exhibited high homology (.95.1% identity)
ith the genotype P[6] strains M37, 1076, RV3, and ST3.
he VP8 region of US1205 was also very closely related
TABLE 3
Neutralization Resistance Pattern of US1205
by VP7-Specific N-MAbs
N-MAb
Virus strain
US1205
(P[6]G9)
F45
(P[8]G9)
F45:1 62,000 280,000
F45:8 280 140,000
WI61:1 820 10,000
TABLE 4
Neutralization Resistance Pattern of US1205
by VP4-Specific N-MAbs
N-MAb
Virus strain
US1205
P[6]
ST3
P[6]
M37
P[6]
F45
P[8]
S-6 780 17,000 2,300 810
S-16 580 170,000 160,000 ,100a
45:4 2600 2,400 10,000 51,000o the comparable region of two virulent P[6] strains
ecently reported in the United States (Santos et al.,
994a,b). All other strains exhibited much less homology
,75.0% identity).
The amino acid region 380–400 of the VP4 of standard
trains that are sensitive or resistant to the N-MAb HS-16
ere compared in an effort to determine sites on strain
S1205 critical for neutralization. This region was se-
ected because antigenic variants of ST-3 resistant to
eutralization by HS-16 selected amino acid substitu-
ions at position 385 (Padilla-Noriega et al., 1995). Strain
S1205 contains the four amino acids at positions 380,
83, 387, and 397, which appear to be conserved in the
tandard P[6] strains, but contains two differences at
ositions 385 and 388 (Table 6). The P2A-specific N-MAb
S-16 was able to neutralize ST3 and M37 but was
nable to neutralize US1205, suggesting that the amino
cid changes at position 388 may be critical. Position 385
ay also be important. Antigenic variants resistant to
eutralization by HS-16 selected substitutions at this
osition. In addition, the ability of HS-16 to neutralize
076 has not been determined. Thus position 385 as well
s 388 could be critical for neutralization of this N-MAb.
The VP8* N-MAb HS-6 that selected variants with a
ubstitution at position 72 (Padilla-Noriega et al., 1995)
as unable to neutralize strain US1205. Consistent with
his finding, US1205 contains asparagine at this position,
n contrast to strains neutralized by this N-MAb, which all
ontain either serine or threonine.
We recently reported the VP7 sequence of strain
S1205 using cDNA amplified from fecal dsRNA (Ra-
achandran et al., 1998). The VP7 sequence of the cul-
ure adapted strain was identical (data not shown). To
xamine the molecular basis of the serological results
ith monoclonal antibodies to the G9 VP7 proteins, the
redicted amino acid sequences in the four major anti-
enic regions (A, B, C, and F) in VP7 of US1205 were
TABLE 5
Comparison of the Sequence of the Gene Encoding VP4 of Human
train US1205 with the Corresponding Sequence of Other Rotavirus
enotypes
P genotype Strain
Identity (%) with US1205
Nucleotide Amino acid
4 RV-5 67.6 72.7
6 M37 95.4 96.8
1076 94.9 95.1
RV-3 95.8 97.4
ST3 95.6 95.8
8 Wa 68.9 74.7
8 F45 69.3 74.9
9 AU-1 66.7 66.4
10 69M 71.3 75.0ligned with the corresponding amino acid sequences
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48 KIRKWOOD ET AL.or the G9 strains WI61, F45, and 116E (Table 7). The
ntigenic A, B, C, and F regions are identical in F45 and
I61. The sequence of US1205 was identical in the
ntigenic B region but had single substitutions in the
ntigenic A and F regions at positions 87 and 242,
espectively. Two substitutions were identified in the
ntigenic C region at positions 208 and 220. The
8[11]G9 strain 116E contained two (positions 87 and
00), one (position 145), and two (positions 208 and 221)
T
Comparison of the Amino Acid Sequence of the
Strain (P type)
380
a a a
S1205 (6) S G G N Y N F Q
37,ST3 (6) — — — — — — — —
076 (6) — — — — — D — —
a (8) T — — S — — — S
45 (8) T — — S — — — S
V-5 (4) T — — S — D — R
Note. The VP4 sequences for the given rotavirus strain was obtained
45 (GenBank Accession No. U30716).
a Indicates position of the amino acids that are conserved in all sta
T
Comparison of the VP7 Antigenic Regio
Antige
87
S1205 T E A S T Q
45, WI61 A — — — — —
16E I — — — — —
Antige
143
S1205 K Y D S T L
45/WI61 — — — — — —
16E — — N — — —
Antige
208
S1205 I T T N T A
45, WI61 T — — — — —
16E T — — — — —
Antige
235
S1205 H K L D V T
45/WI61 — — — — — —
16E — — — — — —
Note. The sequences for the reference strains F45 and 116E were ob
espectively.ifferences from US1205 when compared in the anti-
enic A, B, and C regions; the antigenic F region was
dentical between these strains.
Because US1205-like strains (P[6]G9, subgroup I, short
lectropherotype) have not previously been character-
zed in detail, we also sequenced the NSP4 and VP6
enes. The NSP4 nucleotide and deduced amino acid
equence of US1205 was compared with representatives
f the three NSP4 genotypes (RV-5, genotype A; RV-4,
Region 380–400 of Selected Rotavirus Strains
ino acid sequence
400
a
P V G A W P V M S G G A
— — — — — — — — — — — —
— — — — — — — — — — — —
— — — — — — — — N — — —
— — — — — — — — N — — —
— — — G — — I — N — — —
he following: Wa, M37, ST3, 1076, and RV-5 (Gorziglia et al., 1988) and
6 strains.
, C, and F for Human G9 Rotaviruses
ion A
101
G D T E W K D T
— — — — — — — —
— — — — — — G —
ion B
152
L D M
— — —
— — —
ion C
221
F E E V A T S
— — — — — A —
— — — — — — N
ion F
245
N T C T
T — — —
— — — —
from Green et al. (1989) and Das et al. (1993, Accession No. L14072),ABLE 6
VP5a
Am
I
L
M
—
—
L
from tABLE 7
ns A, B
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49CHARACTERIZATION OF A SEROTYPE P[6]G9 HUMAN ROTAVIRUS STRAINenotype B; and RRV, genotype C). The US1205 NSP4
howed greatest homology to the genotype A strain RV-5
94.1% nucleotide and amino acid identity) and less ho-
ology to the genotype B strain RV-4 (76.0% nucleotide
omology and 82.1% amino acid identity) and the geno-
ype C strain RRV (74.5% nucleotide homology and 80.6%
mino acid identity) (data not shown).
The VP6 nucleotide and deduced amino acid se-
uences of US1205 were compared with representative
trains of VP6 subgroups I and II. US1205 showed great-
st homology to subgroup I strain 1076 (97.5% amino acid
omology) and less with the subgroup II strain Wa (89.9%
mino acid homology), confirming our earlier finding that
S1205 and related strains belong to VP6 subgroup I
FIG. 1. Northern hybridization analysis of Wa, DS-1, and US1205 RNA
sing DIG-labeled total genome probes. RNA was electrophoresed in a
0% (w/v) polyacrylamide gel, stained with ethidium bromide (A), de-
atured, transferred to nylon, and hybridized using the whole genome
robes (B). (A) The hybridization with the Wa genome probe (left), DS-1
enome probe (middle), and US1205 genome probe (right) is indicated.Ramachandran et al., 1998). denogrouping of strain US1205
o investigate the origins of all gene segments, Northern
ybridization analysis of US1205 was carried out using
hole genome probes derived from strains Wa
P1A[8]G1, SGII; Wa genogroup), DS-1 (P1B[4]G2, SGI;
S-1 genogroup), and US1205 (P2A[6]G9, SGI) and hy-
ridized with RNA from Wa, DS-1, and US1205 (Fig. 1).
oth probes reacted with all gene segments of the ho-
ologous virus but less significantly with the viral gene
egments of the nonhomologous genogroup virus. Hy-
ridization of approximately eight bands was obtained
etween the DS-1 probe and the RNA from US1205. A
imilar result was obtained when a US1205 probe was
ybridized with RNA from DS-1. Faint hybrids were ob-
erved for gene segments 1, 5, and 6 against the heter-
logous RNA in both instances. A low level of nonspe-
ific binding was observed for gene segments 7, 10, and
1 when the Wa probe was hybridized to both DS-1 and
S1205 RNA. This nonspecific binding was also noted
or the DS-1 and US1205 probes and Wa RNA. Thus
FIG. 2. Northern hybridization analysis of P[6]G9 strains from four
ifferent U.S. cities using a DIG-labeled US1205 total genome probe.
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50 KIRKWOOD ET AL.S1205 is more related to the DS-1 genogroup than to
he Wa genogroup.
We also analyzed the homology between the genes of
train US1205 and the RNA from other rotavirus isolates
f the same serotype (P[6]G9) but obtained from different
ities in the United States (Ramachandran et al., 1998),
sing the US1205 whole genome probe. All segments for
ach of the isolates hybridized to the US1205 probe,
emonstrating that the four strains analyzed were
losely related (Fig. 2), as suggested by their identical
lectropherotypes. Segment 5 (Figs. 1B and 2) and seg-
ent 10 (Fig. 2) produced a relatively weak signal
gainst homologous strains for all probes, a result pre-
iously noted by others (Palombo and Bishop, 1995).
onetheless, the signals to gene segments 5 and 10
lthough weak are relatively specific for the homologous
robes.
DISCUSSION
his study reports the genetic and antigenic character-
zation of strain US1205, a representative of the P[6]G9
trains with short electropherotype and subgroup I spec-
ficity that were recently detected in stool specimens of
.S. children with diarrhea and that constituted the fourth
ost common strain (Ramachandran et al., 1998). Our
esults have shown that US1205 is closely related to but
ntigenically distinguishable from standard G9 strains
e.g., strain F45) and P[6] strains (e.g., ST-3), while still
aintaining a close genetic similarity. Thus a complete
erologic designation can be assigned to this strain as
2A[6]G9, subgroup I.
The VP7 protein of strain US1205 was shown to pos-
ess serotype G9 specificity, confirming the RT-PCR, nu-
leotide sequencing, Northern hybridization, and mono-
lonal antibody EIA typing results obtained earlier (Ra-
achandran et al., 1998). However, strain US1205 is
ntigenically distinguishable from other G9 strains. The
educed amino acid sequences of VP7 antigenic regions
, B, C, and F differed in three of the regions (A, C, and
). The relationship between amino acid sequence and
-MAb sensitivity was not apparent for the three A re-
ion N-MAbs, F45:8, F45:9, and WI61:1, because no clear
otifs have previously been identified for these N-MAbs
Kirkwood et al., 1993). The substitution at position 87 in
he antigenic A region may be responsible (in part) for
he inability of the region A N-MAbs to neutralize strain
S1205. For example, Kirkwood et al. (1993) reported that
variant of G9 strain F45 selected with N-MAb F45:6 and
aving a substitution at aa position 91 was completely
esistant to N-MAb F45:7, which itself selects variants
ith substitutions at a different A region site (position
6). A similar situation may explain the reduced ability of
he C region N-MAb F45:1 (which selects variants with
utations at position 213) to neutralize US1205. The
bility of F45:1 to neutralize strain US1205 correlatedith the motif NTA at positions 211–213 in the antigenic
region, which was reported previously (Kirkwood et al.,
993) as the critical region for neutralization by this
-MAb. However, changes at positions 208 and/or 220
ay also influence neutralization by this N-MAb. In ad-
ition, the influence of mutations in the A and C region on
ther antigenic regions cannot be discounted. Results
rom variant studies have shown that the VP7 antigenic
egions A and C are in close proximity in the three-
imensional structure of VP7 and interact with each
ther (Taniguchi et al., 1988a; Kirkwood et al., 1993). For
xample an amino acid change in region C (position 213)
f serotype G9 strain F45 can abolish neutralization by
-MAb F45:9, which selected variants in region A, al-
hough other A region N-MAbs were not greatly affected.
hus, the failure of N-MAbs F45:8, F45:9, and WI61:1 to
eutralize US1205 may also be related to C region sub-
titutions. Finally, both the subgroup (VP6) and the VP4
ntigens of US1205 are distinct from the prototype strain
sed here (F45, P1A[8]G9, subgroup II) and the specific
ombination of both outer and inner capsid proteins may
nfluence the expression of particular epitopes. Consis-
ent with this, heterologous combinations of VP4 and VP7
an influence the expression of particular epitopes on
P7 (Dunn et al., 1994).
Neutralization experiments using antisera to reassor-
ants showed that the VP4 gene of strain US1205 en-
odes a protein that has serotype P2A specificity. This
esult was confirmed by sequence analysis of the VP4
ene of US1205, which showed greatest homology to the
2A strains RV-3, M37, ST3, and 1076 (97.4, 96.8, 95.8,
nd 95.1%, respectively). This is in agreement with the
arlier typing results using Northern hybridization anal-
sis and RT-PCR (Ramachandran et al., 1998). However,
ur neutralization experiments with N-MAbs also
howed that the antigenic profile of the VP4 protein of
S1205 is distinct from other serotype P2A strains. Neu-
ralization epitopes of VP4 of human rotaviruses have
een identified on VP8* (72, 148, and 217) and VP5* (305,
83–397, 392–458), using a variety of serotype-specific
nd serotype cross-reactive N-MAbs (Kirkwood et al.,
996; Kobayashi et al., 1990; Padilla-Noriega et al., 1995;
aniguchi et al., 1988b). Specifically, positions 72 and 385
re sites where mutations were selected in variants
esistant to neutralization by the N-MAbs HS-6 and HS-
6, respectively (Padilla-Noriega et al., 1995). Neither of
hese N-MAbs was able to neutralize strain US1205,
uggesting the conserved amino acid differences be-
ween US1205 and strains neutralized by these N-MAbs
t positions 72, 385, and 388 may influence neutraliza-
ion. In addition, the differences in genetic background
etween US1205 and other P2A strains neutralized by
S-6 and HS-16 cannot be discounted because the ori-
in of VP7 can result in loss of VP4 epitopes (Chen et al.,
992).Northern hybridization analysis was conducted on
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51CHARACTERIZATION OF A SEROTYPE P[6]G9 HUMAN ROTAVIRUS STRAIN[6]G9 strains isolated from four cities in the United
tates using a US1205 whole genome probe. As ex-
ected from their identical electropherotypes, all seg-
ents hybridized, demonstrating that the P[6]G9 strains
rom the four U.S. cities belong to the same genogroup.
he observation that DS-1 and US1205 probes produced
even or eight bands when hybridized to the correspond-
ng heterologous RNA strongly suggests that strain
S1205 belongs to the human DS-1 genogroup (Na-
agomi et al., 1989).
The Northern hybridization results were confirmed by
equence analysis of the VP6 and NSP4 genes. Strain
S1205 contained a VP6 protein with subgroup I identity
nd a NSP4 protein with genotype NSP4A identity (DS-1
ike). These findings agree with the general observation
hat subgroup I specificity normally associates with
SP4 genotype A proteins (Kirkwood and Palombo,
997). Both results are consistent with US1205 belonging
o the DS-1 genogroup. The Northern hybridization re-
ults also suggest that the P[6]G9 strains identified in the
nited States have not risen from intergenogroup reas-
ortment between animal and human rotavirus strains, in
ontrast to the P8[11]G9 strain 116E, which resulted from
eassortment between strains from the Wa and bovine
KK3-like) genogroups in India (Das et al., 1993). The
ore likely explanation is that US1205 and related
trains arose through reassortment of the VP7 genes
etween two human strains, possibly between different
enogroups. Likewise, recent studies of Bangladeshi G9
trains showed that among five different reassortant
ypes, all but one strain (31/32) appeared to represent
eassortment of the VP4 or VP7 genes between geno-
roups as far as could be deduced from analysis of
enes encoding subgroup, G and P type, and electro-
herotype (Unicomb et al., manuscript submitted for pub-
ication).
The reason(s) that certain rotavirus VP4 and VP7
enes (e.g., P2A[6], G9) reassort efficiently across
enogroups is unknown. One mechanism may be re-
ated to neutralizing antibodies to common strains. For
xample, the distinct antigenic make-up of strain
S1205 in the outer capsid proteins VP4 and VP7 may
ave provided the P2A[6]G9 strains with the opportu-
ity to avoid recognition by the immune system, which
rovides immunity to standard community strains of
erotypes G1-G4 and P1A[8]. If this hypothesis is true,
t would provide a mechanism for emergence and
eplication of new strain types such as the P[6]G9
ecently identified in India, Bangladesh, and the United
tates. In addition, the identification of P[6]G9 strains
s a potentially important/common serotype in four
ities in the United States indicates that continued
urveillence of rotavirus strains is necessary to mon-
tor the serotypes present in the community and raises
he question whether the current vaccine strategiesill provide protection against these strains. It would (e of considerable interest to conduct neutralization
tudies on sera obtained from children vaccinated
ith the tetravalent vaccine to determine whether
hese strains can be neutralized by vaccine and sera.
his is especially interesting because of the relatively
igh homology between the VP7 proteins of serotype
9 strains and the serotype G3 RRV strain used in the
accine (Ramachandran et al., 1998), raising the ques-
ion whether cross-neutralization and/or cross-protec-
ion may be afforded by the RRV VP7 antigen.
MATERIALS AND METHODS
iruses
uman rotaviruses with P[6]G9 specificity were isolated
rom stools of patients with diarrhea during a survey
onducted in various laboratories throughout the United
tates (Ramachandran et al., 1998). One isolate, US1205,
solated in Indianapolis (IN) in December 1996, was
assaged three times in monkey kidney cells (MA104) in
oller tubes, passaged twice in stationary flasks in the
resence of 5 mg/ml of trypsin, and subsequently plaque
urified three times and then further passaged to pre-
are a seed stock. A single P[6]G9 strain from Philadel-
hia (PA) isolated in 1995 was used in probe analysis
Clark, unpublished data).
Rotavirus strains Wa (P1A[8]G1), M37 (P2A[6]G1), DS-1
P1B[4]G2), 1076 (P2A[6]G2), P (P1A[8]G3), ST3
P2A[6]G4), WI61 and F45 (P1A[8]G9), and 116E
P8[11]G9) were used in this study. All were grown in
A104 cells in the presence of trypsin. Strain WI61xUK
P[5]G9) is a single-segment reassortant containing the
P7 gene from WI61 and all other genes from UK. Addi-
ional reassortants WaxDS-1 (P1A[8]G2), DS-1xUK
P1B[4]G6), DS-1xKC-1 (P1B[4]G10), and ST3xDS-1
P2A[6]G2) are all single-gene reassortants containing
he VP4 gene from the indicated parent.
-MAbs and hyperimmune sera
ntisera were prepared by subcutaneous injection of
uinea pigs with partially purified virus, usually given as
wo doses 4 weeks apart (Wyatt et al., 1984).
The VP7- and VP4-specific N-MAbs F45:1, F45:4, F45:8,
I61:1, HS-6, and HS-16 used in this study have been
escribed previously (Kirkwood et al., 1993, 1996; Padilla-
oriega et al., 1993).
eutralization assays
ntigenic characterization of strain US1205 was per-
ormed by two methods, a 60% plaque reduction neutral-
zation assay in MA104 cells grown in 6-well plates
Hoshino et al., 1984) and an immunofluorescent tech-
ique with MA104 cells grown in 96-well microtiter traysCoulson et al., 1985).
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52 KIRKWOOD ET AL.everse transcription–polymerase chain reaction
RT-PCR)
otavirus dsRNA was isolated from infected cell cultures
sing glass powder after a standard phenol–chloroform
xtraction and ethanol precipitation step. The genes en-
oding VP7, VP4, VP6, and NSP4 were reverse tran-
cribed and amplified by PCR (Gentsch et al., 1992). The
P7, VP6, and NSP4 genes were amplified to full length
sing primers complementary to the 39 end of each of the
NA strands. The primers used for each segment have
een described previously (Gouvea et al., 1990; Palombo
nd Bishop, 1994; Cunliffe et al., 1997). The VP4 gene
as amplified in two portions. An 876-bp fragment was
mplified using the consensus primers Con3 and Con2
Gentsch et al., 1992), covering nt 11–887 containing the
ntire VP8* fragment and 40 amino acids of the VP5*
ragment. The remainder of the VP5* fragment was am-
lified in a 1491-bp fragment covering nt 868–2359 using
primer complementary to Con2 and the 39 end primer
nendG4 (ggt cac atc ctc tat (g/a)ga gct c).
ucleotide sequence determination
he cDNA obtained for each gene was gel-purified and
heir nucleotide sequences were completely determined
n both directions directly from the PCR-derived material
y the dideoxynucleotide chain termination method us-
ng the BIGDye terminator cycle sequencing kit (Applied
iosystems) and specific oligonucleotide primers. Se-
uences were analyzed using the Sequencher program
Gene Codes Corp., Inc., Ann Arbor, MI) and subse-
uently compared with other sequences using the Wis-
onsin Genetics Computer Group computer programs
Devereux et al., 1984; Felsenstein, 1989).
The nucleotide sequences for VP4, VP6, and NSP4 of
S1205 have been deposited with the GenBank data-
ase and assigned Accession Nos. AF079356,
F079357, and AF079358, respectively. The VP7 se-
uence of US1205 was previously reported (Accession
o. AF060487, Ramachandran et al., 1998).
enogroup analysis
orthern hybridization analysis was carried out with
hole genome probes derived from virus strains Wa
P1A[8]G1, SGII, Wa genogroup), DS-1 (P1B[4]G2, SGI,
S1 genogroup), and US1205 (P[6]G9). Probes were gen-
rated by labeling cDNA, derived by reverse transcrip-
ion of purified dsRNA with random hexanucleotide prim-
rs and digoxigenin (DIG)-11–dUTP. Northern hybridiza-
ion was carried out using 10 ng/ml of probe as
escribed previously (Palombo and Bishop, 1995). Viral
sRNA was electrophoresed in a 10% (w/v) polyacryl-
mide gel, denatured, and transferred to a nylon mem-
rane. Prehybridization and hybridization were carried
ut at 50°C. Posthybridization stringency washes werearried out at room temperature and 50°C. Bound probe
as detected using anti-DIG antibody conjugated to al-
aline phosphatase (Boehringer Mannheim, Indianapo-
is, IN) and the chemiluminescent substrate CSPD
Boehringer Mannheim).
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